Cytomegalovirus retinitis in immunocompromised individuals including patients with acquired immunodeficiency syndrome (AIDS). Prevention of CMV disease in transplant patients at risk for CMV disease. Prevention and treatment of life- or sight-threatening cytomegalovirus (CMV) disease in immunocompromised individuals.